UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015

International journal of antimicrobial agents, 2019-04, Vol.53 (4), p.456-466

2019

Volltextzugriff (PDF)

Microbiology and Preclinical Review of Omadacycline

Clinical infectious diseases, 2019-08, Vol.69 (Supplement_1), p.S6-S15

2019

Volltextzugriff (PDF)

Telavancin: Mechanisms of Action, In Vitro Activity, and Mechanisms of Resistance

Clinical infectious diseases, 2015-09, Vol.61 (suppl 2), p.S58-S68

2015

Volltextzugriff (PDF)

In Vitro Antimicrobial Resistance of Urinary Escherichia coli Isolates among U.S. Outpatients from 2000 to 2010

Antimicrobial Agents and Chemotherapy, 2012-04, Vol.56 (4), p.2181-2183

2012

Volltextzugriff (PDF)

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent

Drugs (New York, N.Y.), 2016-04, Vol.76 (5), p.567-588

2016

Volltextzugriff (PDF)

In Vitro Activity of Ceftibuten-Avibactam against β-Lactamase-Positive Enterobacterales from the ATLAS Global Surveillance Program

Antimicrobial agents and chemotherapy, 2023-01, Vol.67 (1), p.e0134622-e0134622

2023

Volltextzugriff (PDF)

Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections - SMART United States 2018-2019

BMC microbiology, 2021-03, Vol.21 (1), p.74-74, Article 74

2021

Volltextzugriff (PDF)

Identification of Blood Culture Isolates Directly from Positive Blood Cultures by Use of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry and a Commercial Extraction System: Analysis of Performance, Cost, and Turnaround Time

Journal of Clinical Microbiology, 2012-10, Vol.50 (10), p.3324-3328

2012

Volltextzugriff (PDF)

In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007–18)

Journal of antimicrobial chemotherapy, 2021-07, Vol.76 (7), p.1808-1814

2021

Volltextzugriff (PDF)

Fosfomycin: A First-Line Oral Therapy for Acute Uncomplicated Cystitis

The Canadian journal of infectious diseases & medical microbiology, 2016-01, Vol.2016 (2016), p.1-10

2016

Volltextzugriff (PDF)

Fidaxomicin: A novel agent for the treatment of Clostridium difficile infection

The Canadian journal of infectious diseases & medical microbiology, 2015-11, Vol.26 (6), p.305-312

2015

Volltextzugriff (PDF)

Intravenous Fosfomycin: An Assessment of Its Potential for Use in the Treatment of Systemic Infections in Canada

The Canadian journal of infectious diseases & medical microbiology, 2018-01, Vol.2018 (2018), p.1-13

2018

Volltextzugriff (PDF)

Evaluation of five chromogenic agar media and the Rosco Rapid Carb screen kit for detection and confirmation of carbapenemase production in Gram-negative bacilli

Journal of clinical microbiology, 2015-01, Vol.53 (1), p.105-112

2015

Volltextzugriff (PDF)

Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007-13

Journal of antimicrobial chemotherapy, 2015-08, Vol.70 (8), p.2199-2202

2015

Volltextzugriff (PDF)

Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15

Journal of antimicrobial chemotherapy, 2018-07, Vol.73 (suppl_7), p.vii12-vii19

2018

Volltextzugriff (PDF)

Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli

The Canadian journal of infectious diseases & medical microbiology, 2018-01, Vol.2018 (2018), p.1-9

2018

Volltextzugriff (PDF)

Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016

Journal of antimicrobial chemotherapy, 2019-08, Vol.74 (Suppl 4), p.iv64-iv71

2019

Volltextzugriff (PDF)

Prevalence of Antimicrobial-Resistant Pathogens in Canadian Hospitals: Results of the Canadian Ward Surveillance Study (CANWARD 2008)

Antimicrobial Agents and Chemotherapy, 2010-11, Vol.54 (11), p.4684-4693

2010

Volltextzugriff (PDF)

Prevalence of Antimicrobial Resistance among Clinical Isolates of Bacteroides fragilis Group in Canada in 2010-2011: CANWARD Surveillance Study

Antimicrobial Agents and Chemotherapy, 2012-03, Vol.56 (3), p.1247-1252

2012

Volltextzugriff (PDF)

Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 study

Journal of antimicrobial chemotherapy, 2019-03, Vol.74 (3), p.645-653

2019

Volltextzugriff (PDF)

In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples: SMART Surveillance United States 2015–2017

Journal of global antimicrobial resistance., 2020-06, Vol.21, p.223-228

2020

Volltextzugriff (PDF)

Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006

Antimicrobial Agents and Chemotherapy, 2008-04, Vol.52 (4), p.1430-1437

2008

Volltextzugriff (PDF)

Oral and Intravenous Fosfomycin for the Treatment of Complicated Urinary Tract Infections

The Canadian journal of infectious diseases & medical microbiology, 2020, Vol.2020 (2020), p.1-11

2020

Volltextzugriff (PDF)

Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011-16 study

Journal of antimicrobial chemotherapy, 2019-08, Vol.74 (Suppl 4), p.iv48-iv54

2019

Volltextzugriff (PDF)

Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015‒2020

The Brazilian journal of infectious diseases, 2023-05, Vol.27 (3), p.102759-102759, Article 102759

2023

Volltextzugriff (PDF)

1 – 25 von 420

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(407)
Mit Volltextzugriff
(407)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(314)
Science & Technology
(314)
Microbiology
(273)
Infectious Diseases
(208)
Pharmacology & Pharmacy
(200)
Humans
(192)
Microbial Sensitivity Tests
(150)
Anti-Bacterial Agents - Pharmacology
(143)
Biological And Medical Sciences
(111)
Medical Sciences
(106)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(88)
Pharmacology. Drug Treatments
(88)
Pseudomonas Aeruginosa
(65)
Antibacterial Agents
(63)
Susceptibility
(58)
Streptococcus Pneumoniae
(56)
Escherichia Coli
(49)
Staphylococcus Aureus
(47)
Drug Resistance, Bacterial
(45)
Surveillance
(42)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015

Microbiology and Preclinical Review of Omadacycline

Telavancin: Mechanisms of Action, In Vitro Activity, and Mechanisms of Resistance

In Vitro Antimicrobial Resistance of Urinary Escherichia coli Isolates among U.S. Outpatients from 2000 to 2010

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent

In Vitro Activity of Ceftibuten-Avibactam against β-Lactamase-Positive Enterobacterales from the ATLAS Global Surveillance Program

Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections - SMART United States 2018-2019

Identification of Blood Culture Isolates Directly from Positive Blood Cultures by Use of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry and a Commercial Extraction System: Analysis of Performance, Cost, and Turnaround Time

In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007–18)

Fosfomycin: A First-Line Oral Therapy for Acute Uncomplicated Cystitis

Fidaxomicin: A novel agent for the treatment of Clostridium difficile infection

Intravenous Fosfomycin: An Assessment of Its Potential for Use in the Treatment of Systemic Infections in Canada

Evaluation of five chromogenic agar media and the Rosco Rapid Carb screen kit for detection and confirmation of carbapenemase production in Gram-negative bacilli

Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007-13

Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15

Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli

Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016

Prevalence of Antimicrobial-Resistant Pathogens in Canadian Hospitals: Results of the Canadian Ward Surveillance Study (CANWARD 2008)

Prevalence of Antimicrobial Resistance among Clinical Isolates of Bacteroides fragilis Group in Canada in 2010-2011: CANWARD Surveillance Study

Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 study

In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples: SMART Surveillance United States 2015–2017

Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006

Oral and Intravenous Fosfomycin for the Treatment of Complicated Urinary Tract Infections

Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011-16 study

Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015‒2020

Suchergebnisse filtern